{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:03:58Z","timestamp":1778936638612,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.humimm.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T18:26:45Z","timestamp":1675880805000},"page":"286-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Loss of anti-AT1R reactivity in ELISA post-adsorption \u2013 False reactivity or interference in the assay?"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0579-1924","authenticated-orcid":false,"given":"Qingyong","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3571-8966","authenticated-orcid":false,"given":"Kurt P.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-519X","authenticated-orcid":false,"given":"Maura","family":"Hardiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-8390","authenticated-orcid":false,"given":"Dennis","family":"Helmick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.humimm.2023.02.001_b0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.humimm.2023.02.001_b0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCRESAHA.113.300752","article-title":"Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond","volume":"113","author":"Xia","year":"2013","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.humimm.2023.02.001_b0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.humimm.2023.02.001_b0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.kint.2021.04.044","article-title":"The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyond","volume":"100","author":"Lefaucheur","year":"2021","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.humimm.2023.02.001_b0025","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/ndt\/gfy008","article-title":"Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients","volume":"33","author":"Fichtner","year":"2018","journal-title":"Nephrol. Dial. Transplant.: Off. Publicat. Eur. Dial. Transplant Assoc. \u2013 Eur. Renal Assoc."},{"issue":"10","key":"10.1016\/j.humimm.2023.02.001_b0030","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.humimm.2023.02.001_b0035","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.humimm.2023.02.001_b0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.humimm.2019.04.007","article-title":"Angiotensin II type I receptor antibodies in thoracic transplantation","volume":"80","author":"Zhang","year":"2019","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2023.02.001_b0045","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0000000000001389","article-title":"A 3-center study reveals new insights into the impact of non-HLA antibodies on lung transplantation outcome","volume":"101","author":"Reinsmoen","year":"2017","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.humimm.2023.02.001_b0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0000000000000185","article-title":"Association of anti-human leukocyte antigen and anti-angiotensin II type 1 receptor antibodies with liver allograft fibrosis after immunosuppression withdrawal","volume":"98","author":"Ohe","year":"2014","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2023.02.001_b0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/ajt.15571","article-title":"Angiotensin II type I receptor agonistic autoantibodies are associated with poor allograft survival in liver retransplantation","volume":"20","author":"Xu","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.humimm.2023.02.001_b0060","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/TP.0000000000001853","article-title":"Non-HLA antibodies impact on C4d staining, stellate cell activation and fibrosis in liver allografts","volume":"101","author":"O'Leary","year":"2017","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.humimm.2023.02.001_b0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/TP.0000000000001439","article-title":"Non-HLA antibodies may accelerate immune responses after intestinal and multivisceral transplantation","volume":"101","author":"Gerlach","year":"2017","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.humimm.2023.02.001_b0070","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ekir.2018.12.011","article-title":"Cytokine profiles associated with angiotensin II type 1 receptor antibodies","volume":"4","author":"Pearl","year":"2019","journal-title":"Kidney Int Rep."},{"issue":"3","key":"10.1016\/j.humimm.2023.02.001_b0075","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2021.09.029","article-title":"Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via beta2-arrestin link to mTOR pathway","volume":"101","author":"Catar","year":"2022","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.humimm.2023.02.001_b0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.kint.2019.01.030","article-title":"Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients","volume":"96","author":"Lefaucheur","year":"2019","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.humimm.2023.02.001_b0085","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.humimm.2016.08.009","article-title":"Angiotensin II type-1 receptor antibody (AT1Rab) associated humoral rejection and the effect of peri operative plasma exchange and candesartan","volume":"77","author":"Carroll","year":"2016","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.humimm.2023.02.001_b0090","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.humimm.2023.02.001_b0095","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.02.001_b0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.trim.2017.12.001","article-title":"Pre-transplant AT1R antibodies correlate with early allograft rejection","volume":"46","author":"Gareau","year":"2018","journal-title":"Transpl. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.02.001_b0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.humimm.2018.02.001","article-title":"Pre-transplant screening for Non-HLA antibodies: who should be tested?","volume":"79","author":"Philogene","year":"2018","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.02.001_b0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOT.0000000000000335","article-title":"Non-HLA antibodies in transplantation: when do they matter?","volume":"21","author":"Philogene","year":"2016","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10.1016\/j.humimm.2023.02.001_b0115","doi-asserted-by":"crossref","unstructured":"R.H. Goggins, K. O\u2019Keefe, K. Wolfe, M.I. Lorber, L.A. Cuchara, The use of Adsorb Out for antibody identification via flow bead immunoassays in difficult patients, Human Immunol. 2005;66(8, Supplement):84.","DOI":"10.1016\/j.humimm.2005.08.161"},{"key":"10.1016\/j.humimm.2023.02.001_b0120","doi-asserted-by":"crossref","unstructured":"M. El Jemli, R. Kamal, I. Marmouzi, A. Zerrouki, Y. Cherrah, K. Alaoui, Radical-scavenging activity and ferric reducing ability of juniperus thurifera (L.), J. oxycedrus (L.), J. phoenicea (L.) and tetraclinis articulata (L.), Adv Pharmacol Sci. 2016;2016:6392656.","DOI":"10.1155\/2016\/6392656"},{"key":"10.1016\/j.humimm.2023.02.001_b0125","doi-asserted-by":"crossref","first-page":"S628","DOI":"10.1097\/01.tp.0000543535.02154.83","article-title":"AT1R antibody assessment: how should we interpret positive results?","volume":"102","author":"Halpin","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2023.02.001_b0130","article-title":"Anti-AT1R antibody detection by ELISA: real or red herring?","volume":"1","author":"Hitchman","year":"2022","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2023.02.001_b0135","unstructured":"Zollner H. Enzyme \u2192 Inhibitor List: A. Handbook of Enzyme Inhibitors. 2nd ed1993. p. 367-8."},{"key":"10.1016\/j.humimm.2023.02.001_b0140","unstructured":"C. Tate, J.A. Thomas, Engineering the angiotensin II type 1 receptor for structural studies (Doctoral thesis), 2015."},{"issue":"3","key":"10.1016\/j.humimm.2023.02.001_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.12.006","article-title":"Distinctive activation mechanism for angiotensin receptor revealed by a synthetic nanobody","volume":"176","author":"Wingler","year":"2019","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.humimm.2023.02.001_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/jcp.36.4.411","article-title":"Immunoperoxidase techniques: the deleterious effect of sodium azide on the activity of peroxidase conjugates","volume":"36","author":"Richardson","year":"1983","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.humimm.2023.02.001_b0155","doi-asserted-by":"crossref","unstructured":"D.K. Bhattacharyya, S. Adak, U. Bandyopadhyay, R.K. Banerjee, Mechanism of inhibition of horseradish peroxidase-catalysed iodide oxidation by EDTA, Biochem J. 1994;298 (Pt 2)(Pt 2):281-8.","DOI":"10.1042\/bj2980281"},{"issue":"11","key":"10.1016\/j.humimm.2023.02.001_b0160","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1016\/S0021-9258(20)65144-4","article-title":"Mechanism of inhibition of horseradish peroxidase by cyclopropanone hydrate","volume":"257","author":"Wiseman","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.humimm.2023.02.001_b0165","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfab344","article-title":"Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis","volume":"37","author":"Kang","year":"2022","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:57:48Z","timestamp":1759319868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0198885923000265"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.02.001","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of anti-AT1R reactivity in ELISA post-adsorption \u2013 False reactivity or interference in the assay?","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}